CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
Spincare matrixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05944250
NCT05944250N/ACompleted
CompareCT.gov

A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB Patients

Stanford University·interventional·Posted Jul 13, 2023·Updated Sep 15, 2025

In Brief

A clinical study evaluating Spincare matrix for Recessive Dystrophic Epidermolysis Bullosa. Completed, enrolled 6 participants across 1 site.

Detailed Summary

Recessive dystrophic epidermolysis bullosa (RDEB) is a subtype of epidermolysis bullosa (EB), an inherited skin condition that presents with blistering skin. The Spincare device, developed by Nanomedic, is the first portable tool that delivers a non-invasive, non-therapeutic electrospun, nanofibrous matrix dressing to wounds to promote healing. The aim of this study is to determine the suitability of this device in RDEB wounds and assess its wound healing properties, safety and tolerability.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecessive Dystrophic Epidermolysis Bullosa
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJul 13, 2023
Enrollment StartSep 19, 2023
Primary CompletionAug 14, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.0 years ago

Interventions

Spincare matrixdevice

The Spincare device, developed by Nanomedic, is the first portable tool that delivers a non-invasive, non-therapeutic electrospun, nanofibrous matrix dressing to wounds to promote healing.